TODD STRATEGY GROUP

Lobbying for KALEO · Pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · $40,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Prescription drug pricing. Medical countermeasure development and procurement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem